医学
化脓性汗腺炎
皮肤病科
阿达木单抗
梅德林
内科学
疾病
政治学
法学
作者
Hans Christian Ring,Julia‐Tatjana Maul,Yiqiu Yao,Jashin J. Wu,Jacob P. Thyssen,Simon Francis Thomsen,Alexander Egeberg
出处
期刊:JAMA Dermatology
[American Medical Association]
日期:2021-12-01
卷期号:158 (2): 184-184
被引量:33
标识
DOI:10.1001/jamadermatol.2021.4805
摘要
In this cohort study, drug survival was comparable between adalimumab, infliximab, and ustekinumab but significantly lower for etanercept. There were no differences in drug survival among biologic-naive and nonnaive patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI